SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-087855
Filing Date
2020-07-29
Accepted
2020-07-29 17:18:26
Documents
14
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025990-1_8k.htm   iXBRL 8-K 25276
2 EXHIBIT 99.1 tm2025990d1_ex99-1.htm EX-99.1 98401
6 GRAPHIC tm2025990d1_ex99-1img01.jpg GRAPHIC 3457
  Complete submission text file 0001104659-20-087855.txt   313391

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20200729.xsd EX-101.SCH 3174
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200729_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200729_pre.xml EX-101.PRE 22702
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2025990-1_8k_htm.xml XML 3608
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 201057981
SIC: 2834 Pharmaceutical Preparations